INT345085

From wiki-pain
Revision as of 10:50, 23 September 2012 by Daniel (Talk | contribs)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
Context Info
Confidence 0.19
First Reported 2010
Last Reported 2010
Negated 0
Speculated 0
Reported most in Body
Documents 1
Total Number 1
Disease Relevance 0.68
Pain Relevance 0.11

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

extracellular region (Cyr61) cell adhesion (Cyr61) extracellular matrix organization (Cyr61)
Cyr61 (Mus musculus)
Pain Link Frequency Relevance Heat
antagonist 15 99.16 Very High Very High Very High
fibrosis 9 61.16 Quite High
agonist 15 5.00 Very Low Very Low Very Low
Neuropathic pain 8 5.00 Very Low Very Low Very Low
dorsal root ganglion 4 5.00 Very Low Very Low Very Low
Pain 4 5.00 Very Low Very Low Very Low
metalloproteinase 4 5.00 Very Low Very Low Very Low
Potency 3 5.00 Very Low Very Low Very Low
alcohol 2 5.00 Very Low Very Low Very Low
Multiple sclerosis 2 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Pseudomonas Infection 1 91.52 High High
Clostridium Difficile Infection 1 90.56 High High
Wound Healing 2 88.28 High High
Adhesions 2 84.20 Quite High
Infection 7 73.84 Quite High
Parainfluenza Virus Infection 2 65.44 Quite High
Fibrosis 6 61.16 Quite High
Systemic Sclerosis 2 57.52 Quite High
Respiratory Syncytial Virus 1 39.68 Quite Low
Pulmonary Fibrosis 3 39.52 Quite Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Wiedmaier et al. have shown that Ki16425, a selective antagonist of LPA1/3 receptors (Ohta et al., 2003), inhibits Cyr61 and CTGF expression (Wiedmaier et al., 2008).
Negative_regulation (inhibits) of Gene_expression (expression) of Cyr61 associated with antagonist
1) Confidence 0.19 Published 2010 Journal British Journal of Pharmacology Section Body Doc Link PMC2989581 Disease Relevance 0.68 Pain Relevance 0.11

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox